Tecan CFO Tania Micki to Depart for New Endeavors
The Tecan Group, a leader in laboratory automation, has recently made an important announcement regarding changes in its executive team. Tania Micki, who has served as Chief Financial Officer since February 2020, will be leaving her role in May 2026. Micki has decided to pursue a new opportunity, demonstrating a strategic shift in her career path.
Commitment to a Smooth Transition
Until her departure, Micki will remain focused on ensuring a seamless transition for her successor. The Tecan Group is committed to maintaining its high standards of financial leadership and governance. The company plans to utilize its succession planning strategies to identify and nominate a new CFO in the coming months.
The Acknowledgments of Leadership Contributions
Monica Manotas, the CEO of Tecan, along with the Board of Directors, expressed their gratitude towards Micki for her substantial contributions. Under her leadership, Tecan has made significant strides in optimizing financial processes and enhancing operational excellence, which are critical for the company's continued growth and success.
About Tecan’s Mission
Founded in Switzerland in 1980, Tecan is dedicated to improving lives and health across the globe. The company designs and manufactures innovative products that empower customers to achieve their healthcare goals. From life science research to clinical applications, Tecan is at the forefront of enabling advancements in laboratory automation.
A Journey of Technological Innovation
Tecan's impact on healthcare innovation is profound. As an original equipment manufacturer, Tecan provides key instruments, components, and medical devices that facilitate laboratory processes world-wide. With a workforce of over 3,000 employees and operations extending across Europe, North America, and Asia, the company’s presence is felt in more than 70 countries.
Financial Performance and Growth
In terms of financial performance, Tecan achieved impressive sales figures, with revenues reaching CHF 934 million in 2024. This financial success is a testament to Tecan's strategic vision and commitment to customer satisfaction in the healthcare industry.
Looking Ahead for Tecan
As Tecan navigates through this transition, the focus remains on fostering innovation and maintaining leadership in laboratory automation. With future developments on the horizon, Tecan is well-positioned to continue its trajectory of growth and success in the industry.
Contact Information for Further Inquiries
For those looking to learn more or reach out to Tecan, please refer to the contact details provided:
Tecan Group
Martin Brändle
Senior Vice President, Corporate Communications & IR
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com
Frequently Asked Questions
Why is Tania Micki leaving Tecan?
Tania Micki has decided to pursue an external opportunity, which prompted her departure from Tecan.
When is Tania Micki's last day at Tecan?
Tania Micki will remain with Tecan until May 2026 to facilitate a smooth transition.
What role has Tania Micki played at Tecan?
As CFO, Tania Micki has significantly contributed to the company’s financial strategy and process optimization.
What is Tecan's primary focus as a company?
Tecan focuses on empowering healthcare innovations through laboratory automation and instrument manufacturing.
What were Tecan's financial outcomes in recent years?
In 2024, Tecan reported sales of CHF 934 million, reflecting its strong position in the market.
